US FDA stepping up enforcement of pharma ad rules, sends letters to companies

By Michael Erman, Jeff Mason and Ahmed Aboulenein WASHINGTON (Reuters) - The U.S. Food and Drug Administration will send out around 100 cease-and-desist enforcement notices and thousands of letters warning pharmaceutical companies that direct-to-consumer ads must comply with regulations that are already on the books, senior administration officials said on Tuesday. The FDA plans to enforce